Your browser doesn't support javascript.
loading
Bullous pemphigoid in a previously healthy adolescent: a case report and literature review.
Giacaman, Narmeen; Abusaada, Rawan Sami N; Tos, Salem M; Ibdah, Mohammad G; Reid Mahagney, Adam M; Rjoob, Asmaa; Abukhalil, Musallam; Salim, Hamza; Musmar, Basel; Zuwahreh, Sufyan.
Afiliación
  • Giacaman N; College of Medicine, Al-Quds University, Abu Dis.
  • Abusaada RSN; College of Medicine, Al-Quds University, Abu Dis.
  • Tos SM; College of Medicine, Al-Quds University, Abu Dis.
  • Ibdah MG; College of Medicine, Al-Quds University, Abu Dis.
  • Reid Mahagney AM; The Hebrew University, Hadassah Medical School, Jerusalem, Israel.
  • Rjoob A; College of Medicine, Al-Quds University, Abu Dis.
  • Abukhalil M; Faculty of Medicine, Islamic University of Gaza, Gaza.
  • Salim H; An-Najah National University, Nablus, Palestine.
  • Musmar B; An-Najah National University, Nablus, Palestine.
  • Zuwahreh S; Internal Medicine Department, Beit-Jala Governmental Hospital, Bethlehem.
Ann Med Surg (Lond) ; 85(10): 5039-5042, 2023 Oct.
Article en En | MEDLINE | ID: mdl-37811084
ABSTRACT

Introduction:

Bullous pemphigoid (BP) is considered the most common bullous autoimmune disorder, characterized by autoantibodies directed against hemidesmosomes in the skin and mucous membranes. It usually affects elderly individuals in the sixth through eighth decades of life, with an average age at onset of 65 years. Only a few cases have been reported in children and teenagers. Case presentation Herein, we report a 17-year-old boy who presented with a pruritic vesicular rash on his arms and legs accompanied by erythema. He was treated at the beginning with topical lotion and acyclovir, but the rash kept deteriorating and eventually bullae appeared, involving also his mouth. A dermatologist was consulted and diagnosed him with BP, and he was treated accordingly.

Discussion:

BP is the most prevalent autoimmune bullous illness, caused by autoantibodies against hemidesmosomes in the basement membrane of skin and mucosal surfaces, which in turn attract immune cells, including T-cells and neutrophils, and activate them, which causes damage to and separation of keratinocytes, resulting in the bullous formation. Diagnosis can be accomplished by recognizing clinical symptoms supported by histopathological and immunofluorescence testing. Steroids, whether topical or systemic, are the cornerstone treatment; depending on the extent of the disease, other immunosuppressant drugs can be used as a second line.

Conclusion:

BP manifestations are polymorphic; physicians should keep in mind that they may present with non-bullous, pruritic lesions, which may persist for some days to several months before bullae appear. Although this disease is rare in the young population, it should be considered in the differential diagnosis of bullous lesions.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Ann Med Surg (Lond) Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Ann Med Surg (Lond) Año: 2023 Tipo del documento: Article
...